X hits on this document

107 views

0 shares

0 downloads

0 comments

10 / 36

CTC NOTICE OF MODIFICATIONS

Version 2.0 Publish Date: April 30, 1999

Grade

Adverse Event Nail changes

  • 0

    1

2

3

4

Petechiae is graded… Photosensitivity

Pigmentation changes (e.g., vitiligo)

Pruritus

Purpura is graded... Radiation dermatitis

Note: Pain associated...

Radiation recall reaction (reaction following chemotherapy in the absence of additional radiation therapy that occurs in a previous radiation port)

G7

Rash/desquamation

Also consider Allergic reaction/hypersensitivity. Note: Stevens-Johnson syndrome...

The Note for Rash/desquamation was changed to Stevens- Johnson syndrome is graded separately as Erythema multiforme in the DERMATOLOGY/SKIN category.

Rash/dermatitis associated with high-dose chemotherapy or BMT studies.

Dermatitis, focal was renamed Rash/dermatitis associated with high-dose chemotherapy or BMT studies and moved under Rash/desquamation (see page 8 for details).

Rash/desquamation associated with graft versus host disease (GVHD) for BMT studies, if specified in

G2

the protocol.

The event name for Rash/desquamation for BMT

was revised to Rash/ desquamation associated with graft versus host disease (GVHD) for BMT studies, if specified in the protocol.

The spelling for the word pruritus was corrected.

Also consider Allergic reaction/hypersensitivity. Note: Stevens-Johnson syndrome...

Cancer Therapy Evaluation Program Common Toxicity Criteria, Version 2.0 DCTD, NCI, NIH, DHHS March 1998

9

Revised March 23, 1998

Document info
Document views107
Page views107
Page last viewedThu Dec 08 16:32:03 UTC 2016
Pages36
Paragraphs1051
Words5565

Comments